home / stock / pand / pand quote
Last: | $60.05 |
---|---|
Change Percent: | 0.22% |
Open: | $59.95 |
Close: | $60.05 |
High: | $60.05 |
Low: | $59.95 |
Volume: | 238,830 |
Last Trade Date Time: | 03/31/2021 04:57:24 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$60.05 | $59.95 | $60.05 | $60.05 | $59.95 | 238,830 | 03-31-2021 |
$59.92 | $59.96 | $59.92 | $60.01 | $59.915 | 278,740 | 03-30-2021 |
$60.01 | $59.93 | $60.01 | $60.01 | $59.93 | 141,095 | 03-29-2021 |
$60 | $60.05 | $60 | $60.12 | $59.96 | 149,068 | 03-26-2021 |
$59.95 | $60.12 | $59.95 | $60.14 | $59.94 | 100,056 | 03-25-2021 |
$59.97 | $60.29 | $59.97 | $60.29 | $59.9 | 780,612 | 03-24-2021 |
$60.09 | $60.04 | $60.09 | $60.5 | $59.91 | 209,658 | 03-23-2021 |
$60.28 | $59.97 | $60.28 | $60.41 | $59.87 | 147,759 | 03-22-2021 |
$60.03 | $60.25 | $60.03 | $60.33 | $59.85 | 1,080,717 | 03-19-2021 |
$59.915 | $60.22 | $59.915 | $60.22 | $59.9 | 53,910 | 03-18-2021 |
$59.95 | $59.91 | $59.95 | $60.3 | $59.8 | 169,172 | 03-17-2021 |
$59.95 | $59.92 | $59.95 | $60 | $59.87 | 72,920 | 03-16-2021 |
$60 | $60 | $60 | $60.03 | $59.8 | 138,331 | 03-15-2021 |
$60.03 | $60.04 | $60.03 | $60.45 | $59.85 | 79,361 | 03-12-2021 |
$60.04 | $59.91 | $60.04 | $60.06 | $59.82 | 305,615 | 03-11-2021 |
$60.03 | $60.02 | $60.03 | $60.07 | $59.8 | 268,238 | 03-10-2021 |
$59.96 | $60.05 | $59.96 | $60.89 | $59.85 | 66,503 | 03-09-2021 |
$59.89 | $60.01 | $59.89 | $60.89 | $59.82 | 248,292 | 03-08-2021 |
$59.89 | $61.45 | $59.89 | $61.45 | $59.79 | 346,930 | 03-05-2021 |
$61.49 | $60.56 | $61.49 | $61.92 | $59.6 | 369,906 | 03-04-2021 |
News, Short Squeeze, Breakout and More Instantly...
Pandion Therapeutics Inc. Company Name:
PAND Stock Symbol:
NASDAQ Market:
Best Biotech Stocks To Buy [Or Sell] Right Now Investors looking for high returns could turn to biotech stocks . These stocks are more volatile than your usual pick. However, could this be the right time to buy biotech stocks after rising Treasury yields continue to spark a tech...
Merck (NYSE: MRK) and Pandion Therapeutics, Inc. (NASDAQ: PAND) have reported entry into a definitive agreement where Merck will acquire Pandion for USD 60 per share in cash or a total equity value of USD 1.85 Billion. “This acquisition builds upon Merck...
Acquisition Adds Pipeline of Candidates Targeting a Broad Range of Autoimmune Diseases Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. (Nasdaq: PAND) today announced that the companies have entered into a definitive agreem...